One single biopsy not sufficient to guide treatment decisions in prostate cancer, say researchers

Friday, September 23, 2016 - 04:01 in Health & Medicine

While the majority of prostate cancers are slow growing and not fatal, some are aggressive and lethal. Genomic fingerprinting can help predict a tumor's aggressiveness and tailor treatment plans, report researchers.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net